To date, EP1 expression has been described in numerous tumor entities, including breast cancer, endometrial cancer, colon cancer, and skin cancer (Gustafsson et al. 2007; Lee et al. 2005; Thorat et al. 2008; Zhu et al. 2018). This evidence concerns the gene PTGER1 and neoplasm.